Merian Life Sciences ApS
CVR 40288589 · Private limited company (ApS) · Active · Low risk
Merian Life Sciences ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 7 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 2.0m and a net result of DKK -37k. CEO: Birgitte Menachem, Neil Goldsmith.
Bankruptcy risk for Merian Life Sciences ApS
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40288589
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Svejagervej 5
2900 Hellerup - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 50k
- Auditor
- Beierholm
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 2 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 84.3% |
| Current ratio | 572% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 281k | DKK 1.1m |
| Net profit | DKK -37k | DKK 835k |
| Equity | DKK 2.0m | DKK 2.2m |
| Total assets | DKK 2.4m | DKK 2.6m |
| Cash | DKK 2.1m | – |
| Short-term debt | DKK 373k | – |
| Tax owed | DKK 141k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 173 | ||
| 1 Jan 2024 – 31 Dec 2024 | 152 | ||
| 1 Jan 2023 – 31 Dec 2023 | 175 | ||
| 1 Jan 2022 – 31 Dec 2022 | 183 | ||
| 1 Jan 2021 – 31 Dec 2021 | 176 | ||
| 1 Jan 2020 – 31 Dec 2020 | 182 | ||
| 25 Feb 2019 – 31 Dec 2019 | 243 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Birgitte Menachem | Current | |
| CEO | Neil Goldsmith | Current | |
| Owner (33%) | Birgitte Menachem | Current | |
| Owner (50%) | Neil Goldsmith | Current | |
| Owner (67%) | Birgitte Menachem | ||
| Owner (20%) | Neil Goldsmith | ||
| Founder | Birgitte Menachem | Current | |
| Founder | Neil Goldsmith | Current |
The CEOs' other companies
Birgitte Menachem – 1 other companies, of which 1 bankrupt
- BAGSVÆRD ERHVERVSSERVICE ApS Bankrupt 10 Dec 2020
Neil Goldsmith – 12 other companies, of which 3 bankrupt
- BAGSVÆRD ERHVERVSSERVICE ApS Bankrupt 10 Dec 2020
- GX BIOSYSTEMS A/S Bankrupt 27 Dec 1999
- Udviklingsselskabet af 28. oktober 2025 ApS Bankrupt 31 Oct 2025
- ANTIANTHRA ApS Fusioneret
- AÏDA ONCOLOGY Aps Active
- Chosa ApS Active
- EVOLVA BIOTECH A/S Fusioneret
- PHYTERA A/S Opløst
- PHYTERA SYMBION ApS Opløst
- PNA DIAGNOSTICS ApS Opløst
- TOPOTARGET A/S Fusioneret
- UNIBIO A/S Active
Address history (0 moves)
| Svejagervej 5, 2900 Hellerup |
Other companies at the same address
- N. B. M. ApS Compulsorily dissolved
Similar companies in Gentofte
- Lica Pharma ApS Hellerup
- SKN computation ApS Gentofte
- WinQure Medicine ApS Klampenborg
- Illum Biotech ApS Charlottenlund
- Novo Nordisk Clinical Innovation Centre A/S Gentofte
- Bollværk ApS Hellerup
- Epitopea ApS Klampenborg
- Spectoceutics ApS Gentofte
- CENEXUM Technologies ApS Gentofte
- Protein Frontiers ApS Gentofte
- ClinOption ApS Dyssegård
- Ascendis Pharma Oncology Division A/S Hellerup
Questions and answers about Merian Life Sciences ApS
Has Merian Life Sciences ApS gone bankrupt?
No, Merian Life Sciences ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Merian Life Sciences ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Merian Life Sciences ApS?
Birgitte Menachem, Neil Goldsmith are the CEOs of Merian Life Sciences ApS.
Who is the auditor of Merian Life Sciences ApS?
Merian Life Sciences ApS most recently used Beierholm.
When was Merian Life Sciences ApS founded?
Merian Life Sciences ApS was founded on 25 February 2019.
What is the equity of Merian Life Sciences ApS?
Equity was DKK 2.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.